Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market 2024-2028
Description
Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market 2024-2028
Global Neuromyelitis Optica Spectrum Disorder (Nmosd) Market 2024-2028
The neuromyelitis optica spectrum disorder (nmosd) market is forecasted to grow by USD 205.1 mn during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the neuromyelitis optica spectrum disorder (nmosd) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, approval of novel therapeutics and strong drug pipeline, and increasing incidence of neuromyelitis optica spectrum disorder.
Technavio's neuromyelitis optica spectrum disorder (nmosd) market is segmented as below:
- By Application
- Hospitals
- Specialty clinics
- Homecare
- By Type
- With aquaporin-4 antibodies
- Without aquaporin-4 antibodies
- By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the neuromyelitis optica spectrum disorder (nmosd) market covers the following areas:
- Neuromyelitis optica spectrum disorder (nmosd) market sizing
- Neuromyelitis optica spectrum disorder (nmosd) market forecast
- Neuromyelitis optica spectrum disorder (nmosd) market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
144 Pages
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
- 2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
- Value Chain Analysis
- 3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- 4 Historic Market Size
- 4.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market 2018 - 2022
- Historic Market Size - Data Table on Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market 2018 - 2022 ($ million)
- 4.2 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ million)
- 4.3 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
- 5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
- 6 Market Segmentation by Application
- 6.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)
- 6.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 6.3 Hospitals - Market size and forecast 2023-2028
- Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
- Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
- 6.4 Specialty clinics - Market size and forecast 2023-2028
- Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
- Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
- Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
- Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
- 6.5 Homecare - Market size and forecast 2023-2028
- Chart on Homecare - Market size and forecast 2023-2028 ($ million)
- Data Table on Homecare - Market size and forecast 2023-2028 ($ million)
- Chart on Homecare - Year-over-year growth 2023-2028 (%)
- Data Table on Homecare - Year-over-year growth 2023-2028 (%)
- 6.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
- 7 Market Segmentation by Type
- 7.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
- 7.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 7.3 With aquaporin-4 antibodies - Market size and forecast 2023-2028
- Chart on With aquaporin-4 antibodies - Market size and forecast 2023-2028 ($ million)
- Data Table on With aquaporin-4 antibodies - Market size and forecast 2023-2028 ($ million)
- Chart on With aquaporin-4 antibodies - Year-over-year growth 2023-2028 (%)
- Data Table on With aquaporin-4 antibodies - Year-over-year growth 2023-2028 (%)
- 7.4 Without aquaporin-4 antibodies - Market size and forecast 2023-2028
- Chart on Without aquaporin-4 antibodies - Market size and forecast 2023-2028 ($ million)
- Data Table on Without aquaporin-4 antibodies - Market size and forecast 2023-2028 ($ million)
- Chart on Without aquaporin-4 antibodies - Year-over-year growth 2023-2028 (%)
- Data Table on Without aquaporin-4 antibodies - Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
- 8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.11 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
- 10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
- 11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
- 12 Competitive Analysis
- 12.1 Companies profiled
- Companies covered
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- 12.4 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key news
- Biogen Inc. - Key offerings
- 12.5 Chugai Pharmaceutical Co. Ltd.
- Chugai Pharmaceutical Co. Ltd. - Overview
- Chugai Pharmaceutical Co. Ltd. - Product / Service
- Chugai Pharmaceutical Co. Ltd. - Key news
- Chugai Pharmaceutical Co. Ltd. - Key offerings
- 12.6 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- 12.7 Hansoh Pharmaceutical Group Co. Ltd.
- Hansoh Pharmaceutical Group Co. Ltd. - Overview
- Hansoh Pharmaceutical Group Co. Ltd. - Product / Service
- Hansoh Pharmaceutical Group Co. Ltd. - Key offerings
- 12.8 HBM Holdings Ltd.
- HBM Holdings Ltd. - Overview
- HBM Holdings Ltd. - Product / Service
- HBM Holdings Ltd. - Key offerings
- 12.9 Horizon Therapeutics Plc
- Horizon Therapeutics Plc - Overview
- Horizon Therapeutics Plc - Product / Service
- Horizon Therapeutics Plc - Key offerings
- 12.10 Mitsubishi Chemical Group Corp.
- Mitsubishi Chemical Group Corp. - Overview
- Mitsubishi Chemical Group Corp. - Business segments
- Mitsubishi Chemical Group Corp. - Key news
- Mitsubishi Chemical Group Corp. - Key offerings
- Mitsubishi Chemical Group Corp. - Segment focus
- 12.11 Opexa Therapeutics Inc.
- Opexa Therapeutics Inc. - Overview
- Opexa Therapeutics Inc. - Product / Service
- Opexa Therapeutics Inc. - Key offerings
- 12.12 TG Therapeutics Inc.
- TG Therapeutics Inc. - Overview
- TG Therapeutics Inc. - Product / Service
- TG Therapeutics Inc. - Key offerings
- 13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- Research methodology
- 13.5 Data procurement
- Information sources
- 13.6 Data validation
- Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- Data synthesis
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
- List of abbreviations
- Exhibits:
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Global Market Characteristics
- Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
- Exhibits5: Executive Summary - Chart on Market Segmentation by Application
- Exhibits6: Executive Summary - Chart on Market Segmentation by Type
- Exhibits7: Executive Summary - Chart on Incremental Growth
- Exhibits8: Executive Summary - Data Table on Incremental Growth
- Exhibits9: Executive Summary - Chart on Company Market Positioning
- Exhibits10: Parent Market
- Exhibits11: Data Table on - Parent Market
- Exhibits12: Market characteristics analysis
- Exhibits13: Value Chain Analysis
- Exhibits14: Offerings of companies included in the market definition
- Exhibits15: Market segments
- Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits20: Historic Market Size - Data Table on Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market 2018 - 2022 ($ million)
- Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
- Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
- Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
- Exhibits25: Five forces analysis - Comparison between 2023 and 2028
- Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
- Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
- Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
- Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
- Exhibits31: Chart on Market condition - Five forces 2023 and 2028
- Exhibits32: Chart on Application - Market share 2023-2028 (%)
- Exhibits33: Data Table on Application - Market share 2023-2028 (%)
- Exhibits34: Chart on Comparison by Application
- Exhibits35: Data Table on Comparison by Application
- Exhibits36: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
- Exhibits37: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
- Exhibits38: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Exhibits39: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
- Exhibits40: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
- Exhibits41: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
- Exhibits42: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
- Exhibits43: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
- Exhibits44: Chart on Homecare - Market size and forecast 2023-2028 ($ million)
- Exhibits45: Data Table on Homecare - Market size and forecast 2023-2028 ($ million)
- Exhibits46: Chart on Homecare - Year-over-year growth 2023-2028 (%)
- Exhibits47: Data Table on Homecare - Year-over-year growth 2023-2028 (%)
- Exhibits48: Market opportunity by Application ($ million)
- Exhibits49: Data Table on Market opportunity by Application ($ million)
- Exhibits50: Chart on Type - Market share 2023-2028 (%)
- Exhibits51: Data Table on Type - Market share 2023-2028 (%)
- Exhibits52: Chart on Comparison by Type
- Exhibits53: Data Table on Comparison by Type
- Exhibits54: Chart on With aquaporin-4 antibodies - Market size and forecast 2023-2028 ($ million)
- Exhibits55: Data Table on With aquaporin-4 antibodies - Market size and forecast 2023-2028 ($ million)
- Exhibits56: Chart on With aquaporin-4 antibodies - Year-over-year growth 2023-2028 (%)
- Exhibits57: Data Table on With aquaporin-4 antibodies - Year-over-year growth 2023-2028 (%)
- Exhibits58: Chart on Without aquaporin-4 antibodies - Market size and forecast 2023-2028 ($ million)
- Exhibits59: Data Table on Without aquaporin-4 antibodies - Market size and forecast 2023-2028 ($ million)
- Exhibits60: Chart on Without aquaporin-4 antibodies - Year-over-year growth 2023-2028 (%)
- Exhibits61: Data Table on Without aquaporin-4 antibodies - Year-over-year growth 2023-2028 (%)
- Exhibits62: Market opportunity by Type ($ million)
- Exhibits63: Data Table on Market opportunity by Type ($ million)
- Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits67: Chart on Geographic comparison
- Exhibits68: Data Table on Geographic comparison
- Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
- Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
- Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
- Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
- Exhibits97: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibits98: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibits99: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibits100: Data Table on Canada - Year-over-year growth 2023-2028 (%)
- Exhibits101: Chart on India - Market size and forecast 2023-2028 ($ million)
- Exhibits102: Data Table on India - Market size and forecast 2023-2028 ($ million)
- Exhibits103: Chart on India - Year-over-year growth 2023-2028 (%)
- Exhibits104: Data Table on India - Year-over-year growth 2023-2028 (%)
- Exhibits105: Market opportunity By Geographical Landscape ($ million)
- Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
- Exhibits107: Impact of drivers and challenges in 2023 and 2028
- Exhibits108: Overview on criticality of inputs and factors of differentiation
- Exhibits109: Overview on factors of disruption
- Exhibits110: Impact of key risks on business
- Exhibits111: Companies covered
- Exhibits112: Matrix on companies position and classification
- Exhibits113: AstraZeneca Plc - Overview
- Exhibits114: AstraZeneca Plc - Product / Service
- Exhibits115: AstraZeneca Plc - Key news
- Exhibits116: AstraZeneca Plc - Key offerings
- Exhibits117: Biogen Inc. - Overview
- Exhibits118: Biogen Inc. - Product / Service
- Exhibits119: Biogen Inc. - Key news
- Exhibits120: Biogen Inc. - Key offerings
- Exhibits121: Chugai Pharmaceutical Co. Ltd. - Overview
- Exhibits122: Chugai Pharmaceutical Co. Ltd. - Product / Service
- Exhibits123: Chugai Pharmaceutical Co. Ltd. - Key news
- Exhibits124: Chugai Pharmaceutical Co. Ltd. - Key offerings
- Exhibits125: F. Hoffmann La Roche Ltd. - Overview
- Exhibits126: F. Hoffmann La Roche Ltd. - Business segments
- Exhibits127: F. Hoffmann La Roche Ltd. - Key news
- Exhibits128: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibits129: F. Hoffmann La Roche Ltd. - Segment focus
- Exhibits130: Hansoh Pharmaceutical Group Co. Ltd. - Overview
- Exhibits131: Hansoh Pharmaceutical Group Co. Ltd. - Product / Service
- Exhibits132: Hansoh Pharmaceutical Group Co. Ltd. - Key offerings
- Exhibits133: HBM Holdings Ltd. - Overview
- Exhibits134: HBM Holdings Ltd. - Product / Service
- Exhibits135: HBM Holdings Ltd. - Key offerings
- Exhibits136: Horizon Therapeutics Plc - Overview
- Exhibits137: Horizon Therapeutics Plc - Product / Service
- Exhibits138: Horizon Therapeutics Plc - Key offerings
- Exhibits139: Mitsubishi Chemical Group Corp. - Overview
- Exhibits140: Mitsubishi Chemical Group Corp. - Business segments
- Exhibits141: Mitsubishi Chemical Group Corp. - Key news
- Exhibits142: Mitsubishi Chemical Group Corp. - Key offerings
- Exhibits143: Mitsubishi Chemical Group Corp. - Segment focus
- Exhibits144: Opexa Therapeutics Inc. - Overview
- Exhibits145: Opexa Therapeutics Inc. - Product / Service
- Exhibits146: Opexa Therapeutics Inc. - Key offerings
- Exhibits147: TG Therapeutics Inc. - Overview
- Exhibits148: TG Therapeutics Inc. - Product / Service
- Exhibits149: TG Therapeutics Inc. - Key offerings
- Exhibits150: Inclusions checklist
- Exhibits151: Exclusions checklist
- Exhibits152: Currency conversion rates for US$
- Exhibits153: Research methodology
- Exhibits154: Information sources
- Exhibits155: Data validation
- Exhibits156: Validation techniques employed for market sizing
- Exhibits157: Data synthesis
- Exhibits158: 360 degree market analysis
- Exhibits159: List of abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
